Dr. Ingo Mellinghoff, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Brain Tumor
Ingo Mellinghoff, MD has run 3 trials for Brain Tumor. Some of their research focus areas include:
Central Nervous System Lymphoma
Ingo Mellinghoff, MD has run 3 trials for Central Nervous System Lymphoma.
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Clinical Trials Ingo Mellinghoff, MD is currently running
Multiple Therapies
for Glioblastoma
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Recruiting
1 award
Phase 2 & 3
10 criteria
Registry
for Brain Tumor
This study will collect medical records, scan results, and complete surveys to create a registry about people with a neurofibromatosis type 1-associated brain tumor (NF1-associated glioma). A registry is a collection of health information about individuals, and it is usually focused on a specific diagnosis or condition. This registry study will help the researchers learn more about the diagnosis, treatment, and quality of life of people with NF1-associated glioma. The researchers want to understand what happens as a result of different treatments for NF1-associated glioma and how these treatments and the disease itself affect people's lives over a period of time. Information collected during this study could affect how doctors diagnose, test, and treat NF1-associated glioma, and the study could help future patients with this type of cancer.
Recruiting
1 award
N/A
4 criteria
More about Ingo Mellinghoff, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Ingo Mellinghoff, MD has experience with
- Ibrutinib
- Temozolomide
- Abemaciclib
- Copanlisib
- Lenalidomide
- Rituximab
Breakdown of trials Ingo Mellinghoff, MD has run
Central Nervous System Lymphoma
Relapse
Brain Lymphoma
Meningioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ingo Mellinghoff, MD specialize in?
Ingo Mellinghoff, MD focuses on Brain Tumor and Central Nervous System Lymphoma. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are IDH negative.
Is Ingo Mellinghoff, MD currently recruiting for clinical trials?
Yes, Ingo Mellinghoff, MD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Ingo Mellinghoff, MD has studied deeply?
Yes, Ingo Mellinghoff, MD has studied treatments such as Ibrutinib, Temozolomide, Abemaciclib.
What is the best way to schedule an appointment with Ingo Mellinghoff, MD?
Apply for one of the trials that Ingo Mellinghoff, MD is conducting.
What is the office address of Ingo Mellinghoff, MD?
The office of Ingo Mellinghoff, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.